Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
ZYME:NASDAQ
Zymeworks Inc
$28.10
+2.44%
(+0.67) 1D
$28.10
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZYME...
Open
$27.51
High
$28.30
Low
$26.93
Mkt. cap
2.07B
Avg. vol.
637.00K
Volume
570.59K
52-wk high
$28.49
52-wk low
$10.88
EPS
-$1.08
Beta
1.20
Shares outstanding
73.75M
No. of employees
264
News stories
From sources across the web
Profile
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange. In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics. Wikipedia
About Zymeworks Inc
CEOKenneth Galbraith
Employees264
Founded2003
HeadquartersMiddletown, Delaware, United States
SectorBiotechnology
Websitezymeworks.com
Next call in 11 days
Thu, May 7, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.10 est.)USD
Revenue / Estimate
-/ (34.94M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
27.11M
48.73M
27.61M
2.52M
Cost of goods sold
35.74M
34.45M
35.58M
31.24M
Cost of revenue
35.74M
34.45M
35.58M
31.24M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.98M
14.95M
14.15M
15.43M
Operating expense
16.98M
14.95M
14.15M
15.43M
Total operating expenses
52.72M
49.40M
49.72M
46.67M
Operating income
-25.61M
-674.00K
-22.11M
-44.15M
Other non operating income
51.00K
-8.00K
26.00K
-18.00K
EBT including unusual items
-22.14M
2.13M
-18.27M
-41.48M
EBT excluding unusual items
-22.14M
2.13M
-18.27M
-41.48M
Income tax expense
496.00K
-186.00K
1.34M
-270.00K
Effective tax rate
-2.24%
-8.73%
-7.31%
0.65%
Other operating expenses
-
-
-
-
Net income
-22.64M
2.32M
-19.60M
-41.21M
Net profit margin
-83.50%
4.76%
-70.99%
-1,638.53%
Earnings per share
-0.30
0.03
-0.26
-0.55
Interest and investment income
3.42M
3.43M
3.53M
2.98M
Interest expense
-
-
-
-
Net interest expenses
3.42M
3.43M
3.53M
2.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.02M
1.82M
-20.56M
-43.07M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer